Welcome to our dedicated page for KRTL HOLDING GROUP news (Ticker: KRTL), a resource for investors and traders seeking the latest updates and insights on KRTL HOLDING GROUP stock.
KRTL Holding Group Inc. reports developments across a diversified subsidiary platform that includes KRTL Biotech, KRTL International Corp., and Neurogen Brain Balancing. Recent company updates center on pharmaceutical and nutraceutical operations, Bolivian manufacturing capacity, anti-infective and antibiotic formulations, and ELIXIR, an electrolyte hydration beverage produced for the Bolivian market.
News about KRTL also covers completed corporate transactions, including KRTL Biotech’s integration with Industria Químico Farmacéutica Sigma Corp. S.R.L., financial reporting updates, PCAOB-audited historical financial statements, shareholder-record remediation, and Rule 15c2-11 compliance efforts tied to public market quotation and governance.
KRTL Holding Group, Inc. has made significant strides since its inception, including acquiring the KRTL stock symbol (OTCMKTS: KRTL) and canceling 6,676,668 common shares. The company focuses on strategic growth, having recruited 27 executives and advisors, and established in-house counsel. Its subsidiary, KRTL Biotech, is advancing in cannabis and hemp extraction technology and has approvals for psilocybin and CBD trials in South Korea. KRTL International, led by CEO Kai Kim, is positioned as a Foreign Advisor to a Special Free Zone in Korea, enhancing opportunities in the cannabis sector.
KRTL Holding Group, Inc. (OTC: KRTL) announced the appointment of Dr. Malcolm A. Leissring as Chief Science Officer of its subsidiary, KRTL Biotech, Inc. Dr. Leissring, a leading neuroscientist, specializes in Alzheimer’s disease and diabetes, with a proven track record in drug discovery. He has published over 60 scientific works and has received numerous grants from prestigious organizations. This strategic hire is aimed at enhancing KRTL's research capabilities and strengthens its position in biotech innovation as the company continues to explore new market opportunities.
KRTL Holding Group, Inc. (OTC: KRTL), previously QUEENCH, Inc. (OTC: QENC), announces the approval of its name and ticker change effective July 25, 2022. This strategic shift aims to enhance its brand and align with its business model, fostering better relationships with stakeholders. The name change does not affect existing shareholder stock, with shares remaining the same. CEO Cesar Herrera emphasized that the name KRTL reflects the company's vision and integrates technologies with logistics. More information is available on their website.